510(k) K844762
K844762 is an FDA 510(k) premarket notification submitted by Wellcome Diagnostics for the device "MENINGOCOCCUS GROUP B MONOCLONAL ANTIBODY ZM-51". The FDA issued a decision of Substantially Equivalent on Jun 4, 1985. The device falls under product code GTJ (Antisera, All Groups, N. Meningitidis), a Class II device regulated under 21 CFR 866.3390. Wellcome Diagnostics has 27 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 4, 1985
- Date Received
- Dec 7, 1984
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antisera, All Groups, N. Meningitidis
- Device Class
- Class II
- Regulation Number
- 866.3390
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Wellcome Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.